Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1926588rdf:typepubmed:Citationlld:pubmed
pubmed-article:1926588lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:1926588lifeskim:mentionsumls-concept:C0039063lld:lifeskim
pubmed-article:1926588lifeskim:mentionsumls-concept:C0005064lld:lifeskim
pubmed-article:1926588lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1926588lifeskim:mentionsumls-concept:C2611154lld:lifeskim
pubmed-article:1926588pubmed:issue3lld:pubmed
pubmed-article:1926588pubmed:dateCreated1991-11-18lld:pubmed
pubmed-article:1926588pubmed:abstractTextThe receptor protein solubilized from synaptic membranes specifically binds [14C] NAD (dissociation constant--0.75 microM, capacity of binding sites--0.0125 nmol of metaid per 1 mg of protein). All the studied benzodiazepines (phenazepam, nitrazepam, clonazepam, flunitrazepam) are able to displace [14C] NAD from its receptor sites, the mixed type of inhibition being manifested. An inhibition constant for flunitrazepam, a ligand of benzodiazepine receptors, equals 10 microM. GABA promotes an inhibiting effect of benzodiazepines. It is supposed that neurotropic action of NAD is realized through the GABA-benzodiazepine complex of neuronal membranes.lld:pubmed
pubmed-article:1926588pubmed:languageruslld:pubmed
pubmed-article:1926588pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1926588pubmed:citationSubsetIMlld:pubmed
pubmed-article:1926588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1926588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1926588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1926588pubmed:statusMEDLINElld:pubmed
pubmed-article:1926588pubmed:issn0201-8470lld:pubmed
pubmed-article:1926588pubmed:authorpubmed-author:ParkhometsP...lld:pubmed
pubmed-article:1926588pubmed:authorpubmed-author:FomenkoA IAIlld:pubmed
pubmed-article:1926588pubmed:authorpubmed-author:DonchenkoG...lld:pubmed
pubmed-article:1926588pubmed:authorpubmed-author:StepanenkoS...lld:pubmed
pubmed-article:1926588pubmed:issnTypePrintlld:pubmed
pubmed-article:1926588pubmed:volume63lld:pubmed
pubmed-article:1926588pubmed:ownerNLMlld:pubmed
pubmed-article:1926588pubmed:authorsCompleteYlld:pubmed
pubmed-article:1926588pubmed:pagination65-9lld:pubmed
pubmed-article:1926588pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:meshHeadingpubmed-meshheading:1926588-...lld:pubmed
pubmed-article:1926588pubmed:articleTitle[Effect of benzodiazepines on NAD binding to synaptic membrane in the rat brain].lld:pubmed
pubmed-article:1926588pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1926588pubmed:publicationTypeEnglish Abstractlld:pubmed